Search Results
Found 1 results
510(k) Data Aggregation
(14 days)
REAADS ANTI-BETA 2 GLYCOPROTEIN I IGA TEST KIT
The REAADS IgA anti-B2GPI Test Kit is an in vitro diagnostic assay for the detection and semiquantitation of IgA anti-B2GPI antibodies in human serum or plasma as an aid for assessing the risk of thrombosis in individuals with systemic lupus erythematosus (SLE) and lupus-like disorders (antiphospholipid syndrome).
The REAADS IgA anti-B2GPI Test Kit is intended to be used by clinical (hospital and reference) laboratories.
Not Found
The provided document is a 510(k) clearance letter from the FDA for the "REAADS IgA anti-B2GPI Test Kit." It confirms the device's substantial equivalence to a legally marketed predicate device but does not contain detailed information about acceptance criteria or a specific study proving the device meets those criteria.
Therefore, I cannot provide the requested information based on the given text.
The document primarily focuses on regulatory clearance and does not include:
- A table of acceptance criteria and reported device performance.
- Sample sizes or data provenance for a test set.
- Information on experts, adjudication methods, or ground truth establishment.
- Details of MRMC comparative effectiveness or standalone studies.
- Sample size or ground truth establishment for a training set.
Ask a specific question about this device
Page 1 of 1